Last Updated: Tuesday, June 11, 2013
Principal Investigator: Jeremy M. Veenstra-VanderWeele, M.D.
Other researchers: Cassandra Newsom, PhD Kevin Sanders, MD
Do you have a family member that has been diagnosed with Fragile X Syndrome?
We invite adults age 16– 50 for a study using an investigational drug. The purpose of the study is to try and find out if this medication is safe and helpful for patients with Fragile X syndrome. This is a randomized, double-blind, 12- week, parallel group, placebo controlled study of the efficacy and safety of RO4917523 in patients with Fragile X syndrome.
You will be asked to come for 7 visits to Vanderbilt University in Nashville, TN. to take part in this research study. A blood draw is required at 7 separate visits.
Adults age 14– 50 with Fragile X for a study using an investigational drug.
Evaluations, study visits, and study drug are provided at no cost. Compensation for transportation will be provided.
7 visits to Vanderbilt University in Nashville, TN.
Adolescents (12-17 years old) with Fragile X syndromeCompensation: Yes
Children with a confirmed diagnosis of Fragile X between 3 and 11 years.Compensation: Yes
People with Fragile X age 5-13Compensation: Yes
Children age 6– 17 with an autism spectrum disorder who are taking an atypical antipsychotic like Risperidone (risperidol), Zyprexa (Olanzapine) and have gained unwanted weight.Compensation: Yes
Children age 6-18 with autism spectrum disorders with and without GI problems.Compensation: Yes
Males ages 18-45 with diagnosis of autism spectrum disorder. Must be verbal.Compensation: Yes
Visit this investigator's people page to list all of their studies together.